Five Oceans Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Five Oceans Advisors's BMY Position: Q3 2026 in Review
Five Oceans Advisors reduced its Bristol-Myers Squibb (BMY) stake by 5.3% in Q3 2026, selling an estimated $14.9K and leaving 4,224 shares worth $264K. The position accounts for 0.1% of the portfolio, ranked #139.
Five Oceans Advisors first reported a position in BMY in Q3 2021 and has held it in 17 quarters since. The position peaked at $484K in Q2 2023. 694 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Five Oceans Advisors held 4,224 shares of Bristol-Myers Squibb worth $264K as of Q3 2026.
- Five Oceans Advisors sold 235 Bristol-Myers Squibb shares in Q3 2026, an estimated $14.9K.
- Bristol-Myers Squibb made up 0.1% of Five Oceans Advisors's portfolio in Q3 2026, its #139 holding.
- Five Oceans Advisors first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 17 quarters since.
- Five Oceans Advisors's Bristol-Myers Squibb position peaked at $484K in Q2 2023.
- 694 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Five Oceans Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.